Cargando…
The CDK1/TFCP2L1/ID2 cascade offers a novel combination therapy strategy in a preclinical model of bladder cancer
Aberrant activation of embryogenesis-related molecular programs in urothelial bladder cancer (BC) is associated with stemness features related to oncogenic dedifferentiation and tumor metastasis. Recently, we reported that overexpression of transcription factor CP2-like protein-1 (TFCP2L1) and its p...
Autores principales: | Heo, Jinbeom, Lee, Jinyoung, Nam, Yun Ji, Kim, YongHwan, Yun, HongDuck, Lee, Seungun, Ju, Hyein, Ryu, Chae-Min, Jeong, Seon Min, Lee, Jinwon, Lim, Jisun, Cho, Yong Mee, Jeong, Eui Man, Hong, Bumsik, Son, Jaekyoung, Shin, Dong-Myung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256744/ https://www.ncbi.nlm.nih.gov/pubmed/35729325 http://dx.doi.org/10.1038/s12276-022-00786-0 |
Ejemplares similares
-
Phosphorylation of TFCP2L1 by CDK1 is required for stem cell pluripotency and bladder carcinogenesis
por: Heo, Jinbeom, et al.
Publicado: (2019) -
Activating transcription factor-2 supports the antioxidant capacity and ability of human mesenchymal stem cells to prevent asthmatic airway inflammation
por: Ju, Hyein, et al.
Publicado: (2023) -
Small‐sized mesenchymal stem cells with high glutathione dynamics show improved therapeutic potency in graft‐versus‐host disease
por: Lim, Jisun, et al.
Publicado: (2021) -
Glutathione dynamics is a potential predictive and therapeutic trait for neoadjuvant chemotherapy response in bladder cancer
por: Kim, YongHwan, et al.
Publicado: (2023) -
Glutathione dynamics determine the therapeutic efficacy of mesenchymal stem cells for graft-versus-host disease via CREB1-NRF2 pathway
por: Lim, Jisun, et al.
Publicado: (2020)